events SAEs

Related by string. * eventing . EVENTS . EVENT . Events . Eventing . Event . eventer : IN NO EVENT . EVENT GIVING RISE TO . Petersen Events Center . Corporate Event Announcement . event shall AME . shared Events Calendar . SYS CON Events / sae . SAEED . SAES . Saeed . Sae : Iranian negotiator Saeed . Helal Saeed Al Marri . nuclear negotiator Saeed . Saeed Jalili Iran . Saeed Azhar . Saeed Al Maktoum * *

Related by context. Frequent words. (Click for all words.) 76 events AEs 73 discontinuations due 71 dose limiting toxicities 69 laboratory abnormalities 68 discontinuations 68 Adverse events 66 treatment emergent adverse 65 SAEs 65 mg BID 64 TYSABRI treated 64 limiting toxicity 64 thromboembolic events 64 AEs 64 plus methotrexate 62 hepatotoxicity 61 INTRON 61 virologic failure 61 active comparator 61 cytogenetic response 61 severe renal impairment 61 dose cohorts 61 valacyclovir 61 adalimumab 60 placebo controlled trials 60 FOLFIRI 60 TORISEL 60 patients receiving ERBITUX 60 dose regimens 60 evaluable patients 60 febrile neutropenia 60 evaluable 59 diabetic neuropathic pain 59 myocardial infarctions 59 bosentan 59 certolizumab pegol 59 hypersensitivity reaction 59 leukopenia 59 ACTEMRA 59 #mg dose [003] 59 hypomagnesemia 59 hypersensitivity reactions 59 myelosuppression 59 lacosamide 59 cardiac toxicity 59 thromboembolism 59 sustained virologic response 58 intracerebral hemorrhage 58 thrombotic events 58 hypercalcemia 58 peginterferon 58 hepatic impairment 58 stable angina 58 adverse reactions 58 systemic absorption 58 plus prednisone 58 6R BH4 58 QT prolongation 58 fingolimod 58 ORENCIA 58 peg IFN 58 tocilizumab 58 abatacept 57 JANUVIA 57 mitoxantrone 57 Median survival 57 dacarbazine 57 adefovir 57 Adverse reactions 57 mcg kg 57 tamsulosin 57 renal impairment 57 FOLFOX 57 mg dose 57 azathioprine 57 infusion reactions 57 subgroup analyzes 56 vertebral fracture 56 peginterferon alfa 2a 56 peginterferon alfa 2b 56 hypokalemia 56 Secondary endpoints 56 plus ribavirin 56 Tolerability 56 REVLIMID ® 56 ONGLYZA 56 eltrombopag 56 ketoconazole 56 tiotropium 56 Cimzia ® 56 anakinra 56 lamotrigine 56 angioedema 56 montelukast 56 REYATAZ 56 composite endpoint 56 randomized Phase III 56 ISENTRESS 56 chronic HCV infection 56 tolerability profile 56 nasopharyngitis 56 PEG INTRON

Back to home page